ACORAI Presents Positive Results in 1,600-Patient CAPTURE-HF Study for its AI-Powered Non-Invasive Multi-Sensor Platform for Improved Heart Failure Patient Management
MINNEAPOLIS, Oct. 6, 2025 /PRNewswire/ — Acorai, a clinical-stage company pioneering non-invasive hemodynamic monitoring for heart failure management, this week announced topline results from the 1,600-patient CAPTURE-HF study (Machine-Learning Estimation of Pulmonary Capillary Wedge and Right Atrial Pressures With a... Read More →
AtaCor Medical Secures $75M Financing to Support the Pivotal U.S. Study of its Extravascular ICD (EV-ICD) System
The novel design of AtaCor’s Atala™ lead aims to provide reliable sensing, antitachycardia pacing (ATP), and shock therapies with no hardware placed in the heart or vasculature SAN CLEMENTE, Calif., Oct. 6, 2025 /PRNewswire/ — AtaCor Medical, Inc., a privately-held... Read More →
DermaSensor Secures $16M to Scale AI-Powered Skin Cancer Detection in Primary Care
MIAMI, FL – October 2, 2025 / EINPresswire.com/ DermaSensor Inc., a medical device technology company transforming skin cancer detection for frontline care, today announced it has raised $16 million in Series B funding to fuel the commercial expansion of its... Read More →
Precision Cell Systems Acquires BennuBio to Enter the 3D Cell Culture Market
LIVERMORE, Calif., Oct. 1, 2025 /PRNewswire/ — Precision Cell Systems (PCS) today announced the acquisition of BennuBio, marking a significant entry into the rapidly growing 3D cell culture market. According to Grand View Research, the global market was valued at... Read More →
Plexāā’s BLOOM⁴³ Prehab™ & Preconditioning Platform for Breast Surgery Launches in the U.S.
LOS ANGELES — Oct. 1, 2025 – Plexāā, a medtech company focused on improving surgical outcomes through devices and digital products, announced today on the first day of Breast Cancer Awareness Month the U.S. launch of its BLOOM⁴³ platform —... Read More →
Subtle Medical Announces Strong 2025 Growth, Expands Market Leadership in AI Imaging
MENLO PARK, Calif., Oct. 1, 2025 /PRNewswire/ — Subtle Medical, a global leader in AI-powered medical imaging, today announced major growth milestones, projecting 2.5x annualized revenue growth in the U.S. for 2025, fueled by strong enterprise demand and new product... Read More →
Zenflow Receives FDA 510(k) Clearance for First-of-Its-Kind Single-Use Cystoscope
Spring® Scope delivers the largest working channel of any flexible single-use cystoscope, enhancing visualization and patient comfort SOUTH SAN FRANCISCO, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) — Zenflow, Inc., a medical device company developing innovative urological solutions, announced it has... Read More →
Relief Cardiovascular Announces First-in-Human Procedures with World’s First Transcatheter Smart Implant for the Treatment of Congestion in Heart Failure
IRVINE, Calif., Sept. 30, 2025 /PRNewswire/ — Relief Cardiovascular, a private company developing transcatheter smart implants to transform the treatment of heart failure, today announced the successful first-in-human use of the Relief System – the world’s first implant designed to... Read More →
Inflammatix Announces Three Landmark Publications in Nature Medicine that Redefine Acute Infection and Sepsis Diagnosis and Treatment
Inflammatix cracks the code of sepsis with an AI-powered test that outperforms the standard of care SEPSIS-SHIELD study validates TriVerity™ as a breakthrough test that can transform hospital triage by providing early clarity on both infection type and illness severity... Read More →
EpiWatch Announces FDA-Cleared Seizure Detection and Alerting App Now Available for Direct Download
Digital care to enhance safety for people living with epilepsy BALTIMORE, MD, UNITED STATES, September 30, 2025 /EINPresswire.com/ — EpiWatch, Inc. today announced that its app-based product, EpiWatch, an FDA-cleared and clinically validated mobile application for seizure detection, alerting and... Read More →